Reactions and commentary on breaking clinical and health economic data presented at top conferences and their impact on practice and policy.
July 12th 2024ASCO 2024: Advances in Non-Small Cell Lung Cancer
A key opinion leader analyzes pivotal non-small cell lung cancer trials presented at ASCO 2024, including LAURA, CHRYSALIS-2, TROPION-Lung05, and CheckMate 9LA, discussing their implications for treatment strategies in non-small cell lung cancer.